Literature DB >> 21073115

Association of serum adiponectin levels with artherosclerosis and the metabolic syndrome in obese children.

Yun-Ling Liu1, Hong-Ri Liang, Hao-Tian Liu, Shu-Ying Li, Ye-ying Zhou, Hui-Ling Cheng, Liao-Sheng Zhou.   

Abstract

BACKGROUND: The atherosclerotic process starts at an early age and is linked to obesity. However, the exact pathophysiological mechanism is poorly understood.
OBJECTIVE: To investigate the relationship between serum adiponectin and metabolic syndrome and early arteriosclerosis.
SUBJECTS: 176 obese and 88 normal children.
METHODS: Ultrasound measurement was performed to investigate IMT, FMD, carotid artery compliance (CAC). Adiponectin was measured by enzyme-linked immunosorbent assay.
RESULTS: Adiponectin levels correlated negatively with obese markers, blood pressure, fasting insulin, high sensitive CRP, HOMA-IR and IMT; marginally positively associated with CAC and HDL-c. The risk of metabolic syndrome increased 3.43 times when adiponectin levels were less than 7060 ng/ml. Heavy obesity, hypertension, low HDL-c, fasting hyperinsulin, High LDL-c and metabolic syndrome percentage were different in three groups according to the cut-off value of adiponectin.
CONCLUSIONS: Low adiponectin levels are associated with a high incidence of metabolic syndrome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21073115     DOI: 10.1515/jpem.2010.122

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  7 in total

1.  Atherogenic dyslipidemia and cardiovascular risk in children with nonalcoholic fatty liver disease.

Authors:  Naim Alkhouri; Christine Carter-Kent; Michael Elias; Ariel E Feldstein
Journal:  Clin Lipidol       Date:  2011-06-01

2.  Endothelial and Metabolic Function Interactions in Overweight/Obese Children.

Authors:  Marco Matteo Ciccone; Maria Felicia Faienza; Maria Altomare; Carmela Nacci; Monica Montagnani; Federica Valente; Francesca Cortese; Michele Gesualdo; Annapaola Zito; Rossana Mancarella; Domenico Leogrande; Domenico Viola; Pietro Scicchitano; Paola Giordano
Journal:  J Atheroscler Thromb       Date:  2016-02-22       Impact factor: 4.928

Review 3.  Obesity pharmacotherapy: current perspectives and future directions.

Authors:  Monika Misra
Journal:  Curr Cardiol Rev       Date:  2013-02-01

4.  Higher adiponectin concentrations are associated with reduced metabolic syndrome risk independently of weight status in Brazilian adolescents.

Authors:  Karen Sparrenberger; Mariana Sbaraini; Felipe Vogt Cureau; Gabriela Heiden Teló; Luciana Bahia; Beatriz D Schaan
Journal:  Diabetol Metab Syndr       Date:  2019-05-24       Impact factor: 3.320

5.  Association of Total and High Molecular Weight Adiponectin with Components of Metabolic Syndrome in Mexican Children

Authors:  Javier A. Magaña Gomez; Daniela Moreno-Mascareño; Carla E. Angulo Rojo; Gisela Duarte de la Peña
Journal:  J Clin Res Pediatr Endocrinol       Date:  2019-09-25

6.  Circulating CTRP7 Is a Potential Predictor for Metabolic Syndrome.

Authors:  Wenjing Hu; Bin Zhan; Qinge Li; Gangyi Yang; Mengliu Yang; Minghong Tan; Shan Geng; Hua Liu; Chen Chen; Dongfang Liu; Ling Li
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-11       Impact factor: 6.055

7.  Is the Leptin/Adiponectin Ratio a Better Diagnostic Biomarker for Insulin Resistance than Leptin or Adiponectin Alone in Adolescents?

Authors:  César Agostinis-Sobrinho; Sofia E de Castro Ferreira Vicente; Sigute Norkiene; Alona Rauckienė-Michaelsson; Justina Kievisienė; Viney Prakash Dubey; Arturas Razbadauskas; Luís Lopes; Rute Santos
Journal:  Children (Basel)       Date:  2022-08-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.